Syremis
United States · $165.0M raised
- Business Model
- B2B
- Total Funding
- $165.0M
- Last Round
- $165.0M Series ADec 2025
- Rounds
- 1
About
Clinical-stage biopharmaceutical company developing novel medicines for mental health conditions.
Summary
Syremis is a Biotech company based in United States. It has raised $165.0M in total across 1 round, most recently a $165.0M Series A round in Dec 2025. Investors include Dexcel Pharma, Third Rock Ventures and Bain Capital Life Sciences.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...